8-K: CTT Pharma Auditor Confirmation Filed
Current Report (8-K) Auditor Confirmation
CTT Pharmaceutical Holdings, Inc. confirms its auditor's agreement with previous disclosures regarding a change in certifying accountant.
Summary
- CTT Pharmaceutical Holdings, Inc. (CTTH) has filed a Form 8-K to address Item 4.01, Changes in Registrant's Certifying Accountant.
- The filing includes a letter from the predecessor independent registered public accounting firm, Holt & Patterson, LLC.
- Holt & Patterson, LLC has read the Company's disclosure in its October 2, 2026, Form 8-K and agrees with the disclosure as it pertains to their firm.
- The company's principal executive, financial, and accounting officer, Ryan Khouri, signed the report on October 9, 2026.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a neutral to slightly negative filing due to its procedural nature and lack of new operational or financial information, indicating a status quo rather than progress.
Negatives
- The filing is procedural and does not provide any new operational, financial, or strategic updates for CTT Pharmaceutical Holdings, Inc.
- It merely confirms agreement with a previous auditor disclosure, offering no insight into the company's current performance or future prospects.
Future Outlook
No forward-looking statements or guidance were provided in this filing.
Management Comments
- The auditor, Holt & Patterson, LLC, has read the Company's disclosure in Item 4.01 of the Company's Current Report on Form 8-K dated October 2, 2026 and agrees with the disclosure as it pertains to our firm.
Industry Context
StockSavvy.ai notes that this filing is a standard procedural update related to auditor changes, which is common in regulatory filings. It does not reflect operational performance or strategic shifts within the pharmaceutical industry.
Stakeholder Impact
- Shareholders: No immediate impact, as the filing is procedural and does not contain new financial or operational information.
Key Dates
| Date | Description |
|---|---|
| 2026-10-02 | Date of the Company's previous Form 8-K filing referenced in the current report. |
| 2026-10-08 | Date of the earliest event reported (filing date of the current 8-K). |
| 2026-10-09 | Date the report was signed by the CEO. |
Keywords
Auditor Change, Certifying Accountant, Form 8-K, SEC Filing, CTT Pharmaceutical Holdings
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.